Peripheral CB1 receptor antagonism for treatment of lower urinary tract symptoms (LUTS)
Latest
Yissum’s Summer 2025 Newsletter showcases new technologies, strategic partnerships, and the launch of the Innovation Lab for National Challenges. Discover how we’re advancing innovation with real-world impact.